BRIEF-Amgen announces positive results from planned overall survival analysis of phase 3 head-to-head ENDEAVOR trial
February 28, 2017 at 18:10 PM EST
* Announces positive results from planned overall survival analysis of phase 3 head-to-head ENDEAVOR trial
